Use and Outcomes of SARS-COV-2 Monoclonal Antibody Therapy in Patients with Primary Immunodeficiency

被引：0
作者：
Monahan, Rose [1 ]
Tang, Monica [1 ]
Pham, Michele [1 ]
机构：
[1] UCSF, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2022年 / 42卷 / SUPPL 1期
关键词：
SARS-CoV-2; Covid-19; monoclonal antibody therapy; REGN-COV2; antibody deficiency;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
146
引用
收藏
页码：S88 / S88
页数：1
相关论文
共 50 条
  • [31] Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2
    Elamari, Saloua
    Motaib, Imane
    Zbiri, Saad
    Elaidaoui, Karim
    Chadli, Asmaa
    Elkettani, Chafik
    PAN AFRICAN MEDICAL JOURNAL, 2020, 37 : 1 - 10
  • [32] Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection
    Boucau, Julie
    Chew, Kara W.
    Choudhary, Manish C.
    Deo, Rinki
    Regan, James
    Flynn, James P.
    Crain, Charles R.
    Hughes, Michael D.
    Ritz, Justin
    Moser, Carlee
    Dragavon, Joan A.
    Javan, Arzhang C.
    Nirula, Ajay
    Klekotka, Paul
    Greninger, Alexander L.
    Coombs, Robert W.
    Fischer, William A.
    Daar, Eric S.
    Wohl, David A.
    Eron, Joseph J.
    Currier, Judith S.
    Smith, Davey M.
    Li, Jonathan Z.
    Barczak, Amy K.
    CELL REPORTS MEDICINE, 2022, 3 (07)
  • [33] Outcomes and implications of diarrhea in patients with SARS-CoV-2 infection
    Shang, Haitao
    Bai, Tao
    Chen, Yuhua
    Huang, Chao
    Zhang, Shengyan
    Yang, Pengcheng
    Zhang, Lei
    Hou, Xiaohua
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (09) : 1049 - 1056
  • [34] Characterization and Outcomes of SARS-CoV-2 Infection in Patients with Sarcoidosis
    Brito-Zeron, P.
    Gracia-Tello, B.
    Robles, A.
    Alguacil, A.
    Bonet, M.
    De-Escalante, B.
    Noblejas-Mosso, A.
    Gomez-de-la-Torre, R.
    Akasbi, M.
    Perez-de-Lis, M.
    Perez-Alvarez, R.
    Ramos-Casals, M.
    VIRUSES-BASEL, 2021, 13 (06):
  • [35] Comparing Immunoassays for SARS-CoV-2 Antibody Detection in Patients with and without Laboratory-Confirmed SARS-CoV-2 Infection
    Leuzinger, Karoline
    Osthoff, Michael
    Draeger, Sarah
    Pargger, Hans
    Siegemund, Martin
    Bassetti, Stefano
    Bingisser, Roland
    Nickel, Christian H.
    Tschudin-Sutter, Sarah
    Khanna, Nina
    Rentsch, Katharina
    Battegay, Manuel
    Egli, Adrian
    Hirsch, Hans H.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2021, 59 (12)
  • [36] Enhancement of SARS-CoV-2 infection and growth by an ACE2-specific monoclonal antibody
    Luo, Guangxiang
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (04)
  • [37] The Antibody Response to SARS-CoV-2 Infection
    Hueston, Linda
    Kok, Jen
    Guibone, Ayla
    McDonald, Damien
    Hone, George
    Goodwin, James
    Carter, Ian
    Basile, Kerri
    Sandaradura, Indy
    Maddocks, Susan
    Sintchenko, Vitali
    Gilroy, Nicole
    Chen, Sharon
    Dwyer, Dominic E.
    O'Sullivan, Matthew V. N.
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (09):
  • [38] Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
    Moran, Angelica
    Beavis, Kathleen G.
    Matushek, Scott M.
    Ciaglia, Carol
    Francois, Nina
    Tesic, Vera
    Love, Nedra
    JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (08)
  • [39] Outcomes in Pregnant Adolescent Patients Infected With SARS-CoV-2
    Nguyen, Anh Quynh
    Murrin, Ellen
    Nasrallah, Sebastian
    Hitchings, Laura
    Wang, Jenny Q.
    VanDillen, Michael B.
    Eletu, Oluwafunmilayo
    Maxwell, G. Larry
    Gomez, Luis M.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2023, 42 (09) : 781 - 786
  • [40] Outcomes in Patients with SARS-CoV-2 and Clostridioides difficile Coinfection
    Sehgal, Kanika
    Fadel, Hind J.
    Tande, Aaron J.
    Pardi, Darrell S.
    Khanna, Sahil
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 1645 - 1648
12345